L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis 0 13.09.2024 04:02 FashionNetwork.com (hk) L'Oreal has joined Abolis Biotechnologies's 35 million euro ($38.6 million) funding round alongside speciality chemicals group Evonik, as part of a deal to develop bio-based ingredients for beauty products. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
